Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
University of California, San Diego
Psilocybin rTMS for Treatment Resistant Depression
University of Texas at Austin
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Icahn School of Medicine at Mount Sinai
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
Unity Health Toronto
Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
Christian Hassager
Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
Insel Gruppe AG, University Hospital Bern
Modulation of the Inflammatory Response in Bariatric Surgery
Hospital HM Nou Delfos
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
University of Colorado, Denver
Study of Psilocybin for Anorexia in Young Adults
Marissa Raymond-Flesch, MD, MPH
MDMA-Assisted CBCT for PTSD vs CBCT RCT
Remedy
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
University of Pittsburgh
Psilocybin-assisted Treatment for Cannabis Use Disorder
Johns Hopkins University
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life
Albany Research Institute, Inc.
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
National Institute of Mental Health (NIMH)
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
Assistance Publique - Hôpitaux de Paris
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Robin Carhart-Harris, PhD, MA
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
Nebulized Ketamine for the Treatment of Major Depressive Disorder
Theresa Jacob, PhD, MPH
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
Oregon Health and Science University
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
Margaux M. Salas, PhD
At-Home tDCS as Maintenance Therapy
Technical University of Munich
Psilocybin in Cancer Pain Study
Yvan Beaussant, MD, MSci
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Rush University Medical Center
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sharmin Ghaznavi
Imaging Depression in Parkinson's Disease
Yale University
Tolerability of MDMA in Schizophrenia
Anya Bershad, MD, PhD
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Dr. Inge Winter
Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
4th Military Clinical Hospital with Polyclinic, Poland
Low-Dose Ketamine Infusion During Burn Wound Care
University of Tennessee
Lysergic Acid Diethylamide (LSD) in Palliative Care
University Hospital, Basel, Switzerland
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
University of Rochester
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
University Hospital, Ghent
Effect of Opioid-Free vs Opioid-Based Anesthesia on Postoperative Pain and Emergence Agitation in Children Undergoing Cleft Surgery
Iva Smiljanić
Belief Updating in Treatment Resistant Depression
Assistance Publique - Hôpitaux de Paris
The Impact of Psilocybin on Pain in Fibromyalgia Patients
Maastricht University
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Lindsay Maguire, MD
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Antonios Likourezos
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital Tuebingen
Opioid-free Anesthesia as an Alternative to General Anesthesia in Abdominal Surgery
Jagiellonian University
Psilocybin in Chronic Low Back Pain and Depression
Johns Hopkins University
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Section for Affective Disorders; Northern Stockholm Psychiatry
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
MDMA for Co-occurring PTSD and OUD After Childbirth
University of New Mexico
Non-steroidal Anti-inflammatory in Cardiac Surgery
Centre Hospitalier Universitaire, Amiens
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of Calgary
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
University of California, Berkeley
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Reinier de Graaf Groep
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.